Navigation Links
Oral bisphosphonate did not improve prognosis for patients with breast cancer
Date:12/7/2011

SAN ANTONIO Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate.

Volker Mbus, Ph.D., head of the department of obstetrics and gynecology at Klinikum Frankfurt Hchst GmbH in Frankfurt, presented the results from the German Adjuvant Intergroup Node Positive (GAIN) Study, at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.

Mbus and his colleagues randomly assigned 3,023 patients with breast cancer to two different chemotherapy regimens and then further assigned them to 50 milligrams of oral ibandronate or observation. After a median follow-up of 38.7 months, "we found no significant difference between groups in the primary endpoint" of disease-free survival, Mbus said.

He described these results as "disappointing" compared with other studies. In the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer (AZURE) trial, for example, Mbus said that the subgroup of postmenopausal patients showed an improvement in recurrence-free and overall survival.

"So far, clinical trials of adjuvant bisphosphonates in early breast cancer have shown variable results, independent from their application (oral compared with intravenous)," Mbus said.

More recently, two trials the Austrian Breast & Colorectal Study Group (ABCSG-12) and the Zometa-Femara Adjuvant Synergy Trial (ZO-FAST) have shown significant benefit in patients with hormone receptor-positive breast cancer who were postmenopausal and received an endocrine treatment only.

Mbus said that in the AZURE trial, 95 percent of patients received chemotherapy and only postmenopausal patients showed an improvement in the zoledronic acid group. "In our [GAIN] trial, all patients received dose-dense chemotherapy, and unfortunately, we could not show a benefit in any subgroup," he said. "We sp
'/>"/>

Contact: Jeremy Moore
Jeremy.Moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Some bisphosphonates users unfamiliar with drugs possible side effects on oral health
2. New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients
3. Immediate bisphosphonate use with endocrine therapy reduced recurrence and increased survival in postmenopausal early breast cancer
4. A New Website Series Improves Appearance and Health City by City
5. CustomerCentric Selling and Kadient Announce Joint Event in Boston to Launch Strategic Partnership for Sales Enablement and Improvement
6. Exercise Success for People Over 50: Reports of Improved Fitness, Circulation and Balance
7. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
8. Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity
9. Retired Military Brass Support First Ladys Call to Reduce Child Obesity, Improve Nutrition
10. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
11. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Doylestown, PA (PRWEB) , ... July 01, 2015 ... ... Services national sales training leaders Lora Posey (Manager, National Sales Training and Development) ... Trainers and Educators Network (LTEN) Conference in Phoenix, AZ. LTEN brings together learning ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the ... 5K on August 15-16th (MSG Keys’ birthday) in memory of her late husband and ... soldier and recipient of the Bronze Star Medal, died during a Special Forces training ...
(Date:7/1/2015)... ... 2015 , ... “Well-meaning social policy often has unintended and ... School of International and Public Affairs. , The researchers examined longitudinal ... Survey on Drug Use and Health, which is a nationally representative survey of ...
(Date:7/1/2015)... Orange, NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in ... the National Scoliosis Foundation, it affects 2 to 3 percent of the population, or an ... scoliosis most often develops in children between the ages of 10 and 15. Most types ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... delicatessen products, is helping families get ready for Independence Day celebrations with new ... these easy and versatile options are perfect for any summertime get together. , ...
Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... Public Health; Progress Needed,in Other Key Areas, SPRINGFIELD, ... three very low grades in tobacco control policies from,the ... which,highlighted significant progress in smoke free air and outlined ... cigarette tax and youth,access. Illinois received the following grades:, ...
... Funding will allow the Washington Association of Sheriffs and ... through a 30-Day DNA testing program, OLYMPIA, Wash., ... President on December 26, 2007 included a $961,000 earmark,for ... to,continue the important DNA Stranger Rape Program., "Without ...
... strong financial and clinical foundation, in preparation for release of technology ... ... for diabetes, EMERYVILLE, Calif., Jan. 10 Tethys Bioscience ... to,release Tethys Diabetes PreDxTM, a multi-biomarker technology that provides,a more complete ...
... causes neurodegenerative disorder called spinal muscular atrophy , , THURSDAY, ... wrong while she was still pregnant with her second child. ... one side of her body, leaving her stomach flat. ... born. "He had a very weak cry, very little muscle ...
... in the Jan. 10 edition of the New England ... treatment and diagnosis of LAM, or lymphangioleiomyomatosis, a progressive ... childbearing years. There currently are no treatments for ... may be going misdiagnosed or undiagnosed. , Researchers ...
... found in human hair shows promise for promoting the regeneration ... option when nerves are cut or crushed from trauma. ... Forest University School of Medicine reported that in animal studies ... and improve nerve function compared to current treatment options. , ...
Cached Medicine News:Health News:American Lung Association Report Gives Illinois Mixed Grades 2Health News:American Lung Association Report Gives Illinois Mixed Grades 3Health News:Congressional Budget Includes Earmark to Keep Washington's Sexual Assault DNA Program Moving Forward 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 2Health News:Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 2Health News:Years-Long Search Unlocks Deadly Genetic Disease 3Health News:Years-Long Search Unlocks Deadly Genetic Disease 4Health News:New research demonstrates potential diagnosis, treatment benefits 2Health News:New research demonstrates potential diagnosis, treatment benefits 3Health News:New research demonstrates potential diagnosis, treatment benefits 4Health News:Protein in human hair shows promise for regenerating nerves 2Health News:Protein in human hair shows promise for regenerating nerves 3
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "2015 Strategies in ... offering. This new 175-page report provides ... including diabetes (strips and meters), pregnancy, ovulation, and ... growth, regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Technologies, Inc. (NYSE Amex: PTN ) today announced ... Palatin,s request to begin a Phase 2A proof-of-concept human trial ... administered formulation of PL-3994, an NPR-A agonist compound, in development ... "We are excited about the prospect of advancing PL-3994 into ...
... 3, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... preventive vaccines against cancers and infectious diseases, announced today that ... company overview at the ROTH 23rd Annual Growth Stock Conference ... A live and archived webcast will be accessible ...
Cached Medicine Technology:FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for Asthma 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 3
Straight shafts with 1 x 2 teeth. Serrated handle with polished finish. Delicate teeth....
Straight shafts with 0.12 mm teeth and 5 mm tying platform. Serrated handle with polished finish. Manufactured in titanium....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: